Phase 0 clinical trials

Last revised by Henry Knipe ◉ ◈ on 17 Apr 2015

Citation, DOI, disclosures and article data

Citation:

Gaillard F, Knipe H, Phase 0 clinical trials. Reference article, Radiopaedia.org (Accessed on 24 Mar 2023) https://doi.org/10.53347/rID-30061

DOI:

https://doi.org/10.53347/rID-30061

Permalink:

https://radiopaedia.org/articles/30061?iframe=true

rID:

30061

Article created:

16 Jul 2014, Frank Gaillard ◉ ◈

Disclosures:

At the time the article was created Frank Gaillard had no recorded disclosures.

View Frank Gaillard's current disclosures

Last revised:

17 Apr 2015, Henry Knipe ◉ ◈

Disclosures:

At the time the article was last revised Henry Knipe had no recorded disclosures.

View Henry Knipe's current disclosures

Revisions:

1 time, by 1 contributor - see full revision history and disclosures

Tags:

Phase 0 clinical trials are the first step in evaluating a possible new drug on humans, and are designed to evaluate the pharmacodynamics and pharmacokinetics of the drug in humans. They are typically performed on a small number of subjects (e.g. a dozen or so) who are administered subtherapeutic doses ¹.

References

Related articles: Research

Promoted articles (advertising)

ADVERTISEMENT: Supporters see fewer/no ads